Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.5.5 indicates a minor page update. It does not change the clinical trial data, eligibility criteria, or how the page is used.
    Difference
    0.1%
    Check dated 2026-06-05T09:58:32.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    - Revision indicator updated from v3.5.3 to v3.5.4, reflecting a new build of the page.
    Difference
    0.1%
    Check dated 2026-05-15T05:44:38.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The site’s release/version indicator for the ClinicalTrials.gov study page has been updated from v3.5.2 to v3.5.3, reflecting a platform or content release change rather than any modification to the study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:45:31.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:51.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The study status changed from Recruiting to Active, not recruiting. Several study contact details and names were removed from the page.
    Difference
    3%
    Check dated 2026-03-26T11:23:19.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; no visible changes to study content.
    Difference
    0.0%
    Check dated 2026-03-19T05:01:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.